This report shows a comparison of two ulcer therapies (A and B). It breaks down the time of last visit in months, age in years, and duration of the disease. The t-test evaluates these to variables in orders to see if they are equal or whether the means of both groups are statistically different. Evidently, group B has more Participants than group A. There are 24 participants in group B whereas in group A there are only 19. So this makes me think that maybe because of the elevated number that the results of group b will be higher. This hypothesis stand to be true when looking at the time of last visit as well as age in years. However, the mean for the duration of the disease is higher for group A. Remarkably, it appears that the mean variance for ulcer therapy in group A is higher in the category of duration of disease.

For the independent-sample’s t test the variances assumed for the time of last visit in months is 0.22, and is slightly higher than the identical variances assumed. Ideally, for this test, the subjects should be randomly assigned to two groups, so that any difference in response is due to the treatment (or lack of treatment) and not to other factors (IBM, 2017).

The same variances are now not assumed in different variables, together using age in years and period of the disease also have slightly better ratios than the variances assumed. But, the barrier of the t-test is that it is primarily based on assumptions of the variances. Assuming that the lower the standard error suggests specifically that it may be supported as shown. It can be concluded that the smaller known error implies as indicated with the aid of the variable of the length of the disease, is extra precise in as far as powerful implementation of ulcer therapy is concerned.

When Considering the variable of age in years the T-test value is -0.084 which is less than 0.826.With those results we can then further know that the null hypothesis is rejected and conclude that there is a difference in ages between treatment of ulcer therapies in groups A and B. As we look at the duration of the disease the t-test value is 0.436 which is greater than 0.364 which accepts the null hypothesis and shows that there is no difference between duration of disease in treatment of ulcer therapies in groups A and B. My recommendations would be to do yearly or semi yearly evaluations. As far as elderly patients this should be taken more seriously and be apart of regular check ups. Patients suffering from ulcers and the pain should continue follow up appointments.